VELCADE (Bortezomib) is used to treat patients with multiple myeloma and treatment of patients with mantle cell lymphoma

VELCADE is a proteasome inhibitor indicated for treatment of patients with multiple myeloma and treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy. VELCADE (Bortezomib) for Injection should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection. Bortezomib was approved for medical use in the United States in 2003 and in Europe in 2004. It is on the World Health Organization's List of Essential Medicines, which lists the safest and most effective medicines needed in a health system.

Trade Name: VELCADE ® (bortezomib) for Injection. For subcutaneous or intravenous use

Generic Name: bortezomib

Single-use vial contains 3.5 mg of bortezomib as lyophilized powder.

VELCADE (Bortezomib) suppliers in India

For procurement cost of VELCADE (Bortezomib) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.

The order for VELCADE (Bortezomib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

VELCADE (Bortezomib) for Injection

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to VELCADE (Bortezomib) on the Named Patient Import basis in India.

VELCADE (Bortezomib)

News / Update for Velcade (Bortezomib).

For Velcade (Bortezomib) for injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Venclexta-Darzalex Combos Show Strong Response Rates in Multiple Myeloma Trial, Early Data Show For More Details

New Drug Benefits Patients With Myeloma Who Are Resistant to All Therapies For More Details

VELCADE (Bortezomib) manufacturer and suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand VELCADE (Bortezomib) on prescription and Import License in Patient's Name only.

For overseas patients, VELCADE (Bortezomib) can be made available in Send your enquiry to find VELCADE (Bortezomib) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Steps to access VELCADE (Bortezomib) on the Named Patient Import basis.

Step 1.
You send a request for your medicine online:-
Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2.
We verify your prescription and medical details:-
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3.
We source your medicine:-
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4.
We deliver your medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation for Named-Patient import to access VELCADE (Bortezomib).

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number :07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 6,000 patients.

Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur